title: Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis.
authors.forename: Marianna
authors.initials: M
authors.lastname: Colagrande
authors.forename: Mauro
authors.initials: M
authors.lastname: Di Ianni
authors.forename: Raffaella
authors.initials: R
authors.lastname: Ciurnelli
authors.forename: Massimo
authors.initials: M
authors.lastname: Gallucci
authors.forename: Guglielmo
authors.initials: G
authors.lastname: Mariani
authors.forename: Antonio
authors.initials: A
authors.lastname: Tabilio
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008578:Meninges / Q000473:pathology; D008875:Middle Aged; D009918:Orbital Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010954:Plasmacytoma / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine